Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Immune Evasion | 6 | 2021 | 2081 | 1.02 | Why? |
| Genetic Fitness | 1 | 2021 | 339 | 0.74 | Why? |
| Cross Reactions | 4 | 2021 | 4374 | 0.54 | Why? |
| Spike Glycoprotein, Coronavirus | 9 | 2021 | 37182 | 0.37 | Why? |
| Antibodies, Monoclonal | 9 | 2021 | 8041 | 0.34 | Why? |
| Antibodies, Neutralizing | 9 | 2021 | 25288 | 0.24 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.22 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.19 | Why? |
| Epitope Mapping | 2 | 2021 | 1240 | 0.19 | Why? |
| Diamines | 1 | 2018 | 83 | 0.18 | Why? |
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 65 | 0.18 | Why? |
| Protein Kinase Inhibitors | 2 | 2018 | 1585 | 0.17 | Why? |
| RNA Splicing | 1 | 2018 | 119 | 0.17 | Why? |
| Pyridazines | 1 | 2017 | 86 | 0.17 | Why? |
| Renin | 1 | 2018 | 167 | 0.17 | Why? |
| Protein-Tyrosine Kinases | 1 | 2018 | 158 | 0.17 | Why? |
| Drug Design | 3 | 2018 | 2627 | 0.16 | Why? |
| Models, Molecular | 5 | 2021 | 7616 | 0.16 | Why? |
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 230 | 0.16 | Why? |
| Epitopes, B-Lymphocyte | 2 | 2021 | 1267 | 0.16 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.15 | Why? |
| Repressor Proteins | 1 | 2017 | 232 | 0.15 | Why? |
| Benzimidazoles | 1 | 2018 | 275 | 0.14 | Why? |
| Proto-Oncogene Proteins | 1 | 2017 | 340 | 0.14 | Why? |
| Antibodies, Viral | 9 | 2021 | 51949 | 0.13 | Why? |
| Quinolines | 1 | 2018 | 403 | 0.13 | Why? |
| Virulence | 1 | 2021 | 2172 | 0.13 | Why? |
| Neutralization Tests | 6 | 2021 | 6698 | 0.13 | Why? |
| Protein Interaction Maps | 2 | 2017 | 1333 | 0.12 | Why? |
| Piperidines | 1 | 2018 | 795 | 0.11 | Why? |
| Mutation | 5 | 2021 | 12376 | 0.10 | Why? |
| Pyrimidines | 1 | 2018 | 1557 | 0.10 | Why? |
| Protein Structure, Tertiary | 3 | 2018 | 1565 | 0.09 | Why? |
| Small Molecule Libraries | 1 | 2017 | 1060 | 0.09 | Why? |
| Cryoelectron Microscopy | 3 | 2021 | 2372 | 0.09 | Why? |
| Cell Line | 2 | 2021 | 12040 | 0.09 | Why? |
| Vaccines, Synthetic | 1 | 2021 | 3231 | 0.09 | Why? |
| Animals | 10 | 2021 | 78931 | 0.09 | Why? |
| Immunoglobulin Fab Fragments | 2 | 2021 | 556 | 0.09 | Why? |
| Protein Domains | 4 | 2021 | 6563 | 0.09 | Why? |
| Half-Life | 2 | 2018 | 298 | 0.08 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.08 | Why? |
| HEK293 Cells | 4 | 2021 | 8394 | 0.08 | Why? |
| Molecular Dynamics Simulation | 4 | 2020 | 4155 | 0.07 | Why? |
| Peptidyl-Dipeptidase A | 3 | 2020 | 9659 | 0.07 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.06 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.06 | Why? |
| Binding Sites | 3 | 2020 | 6201 | 0.06 | Why? |
| Protease Inhibitors | 1 | 2018 | 3630 | 0.06 | Why? |
| Peptide Mapping | 1 | 2021 | 112 | 0.06 | Why? |
| Structure-Activity Relationship | 2 | 2018 | 2219 | 0.05 | Why? |
| Jurkat Cells | 1 | 2021 | 273 | 0.05 | Why? |
| Crystallography, X-Ray | 2 | 2018 | 2689 | 0.05 | Why? |
| Rats | 2 | 2018 | 2764 | 0.05 | Why? |
| Viral Vaccines | 1 | 2021 | 7560 | 0.05 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2021 | 530 | 0.05 | Why? |
| Genes, myc | 1 | 2018 | 15 | 0.05 | Why? |
| Protein Structure, Quaternary | 1 | 2020 | 455 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2020 | 616 | 0.05 | Why? |
| Rats, Inbred Lew | 1 | 2017 | 45 | 0.05 | Why? |
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 43 | 0.05 | Why? |
| Amino Acid Motifs | 1 | 2020 | 620 | 0.05 | Why? |
| Protein Subunits | 1 | 2021 | 755 | 0.04 | Why? |
| CHO Cells | 1 | 2020 | 831 | 0.04 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2020 | 349 | 0.04 | Why? |
| Microscopy, Electron | 1 | 2020 | 830 | 0.04 | Why? |
| Amines | 1 | 2017 | 67 | 0.04 | Why? |
| Cricetulus | 1 | 2020 | 936 | 0.04 | Why? |
| Two-Hybrid System Techniques | 1 | 2017 | 116 | 0.04 | Why? |
| Immunoglobulin Fc Fragments | 1 | 2021 | 691 | 0.04 | Why? |
| Membrane Fusion | 1 | 2021 | 713 | 0.04 | Why? |
| Biological Availability | 1 | 2018 | 388 | 0.04 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Drug Evaluation, Preclinical | 2 | 2018 | 3347 | 0.04 | Why? |
| Hydrogen Bonding | 1 | 2018 | 599 | 0.04 | Why? |
| Humans | 15 | 2021 | 930598 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2020 | 813 | 0.04 | Why? |
| Surface Plasmon Resonance | 1 | 2017 | 440 | 0.04 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.03 | Why? |
| Inhibitory Concentration 50 | 1 | 2017 | 907 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2021 | 1706 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2021 | 2134 | 0.03 | Why? |
| Arthritis | 1 | 2017 | 288 | 0.03 | Why? |
| Betacoronavirus | 4 | 2021 | 204454 | 0.03 | Why? |
| Protein Binding | 2 | 2020 | 11430 | 0.03 | Why? |
| Ligands | 1 | 2017 | 1300 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2021 | 10998 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2018 | 2739 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2020 | 2093 | 0.03 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| High-Throughput Screening Assays | 1 | 2017 | 1783 | 0.02 | Why? |
| Epitopes | 1 | 2020 | 4113 | 0.02 | Why? |
| Immunologic Memory | 1 | 2020 | 3362 | 0.02 | Why? |
| Female | 4 | 2021 | 380317 | 0.02 | Why? |
| Aged | 2 | 2021 | 215776 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.02 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.02 | Why? |
| B-Lymphocytes | 1 | 2020 | 4418 | 0.02 | Why? |
| Monocytes | 1 | 2017 | 2978 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Male | 2 | 2021 | 367725 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Adult | 1 | 2021 | 244371 | 0.02 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 7868 | 0.01 | Why? |
| Molecular Docking Simulation | 1 | 2017 | 6902 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
Snell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(125)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(180)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_